In young post-myocardial infarction male patients elevated plasminogen activator inhibitor-1 correlates with insulin resistance and endothelial dysfunction

Heart and Vessels

Volumn 28, Issue 5, 2013, Pages 570-577

  Eržen, Barbara ^a   Šabovič, Mišo ^a  

^a UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

Author keywords

Endothelial dysfunction; Insulin resistance; Myocardial infarction; Obesity; Plasminogen activator inhibitor 1; Young adult male

Indexed keywords

C REACTIVE PROTEIN; FIBRINOGEN; INTERLEUKIN 6; PLASMINOGEN ACTIVATOR INHIBITOR 1; TUMOR NECROSIS FACTOR ALPHA;

ABDOMINAL OBESITY; ADULT; ARTERIAL WALL THICKNESS; ARTICLE; BODY MASS; BRACHIAL ARTERY; CARDIOVASCULAR RISK; CLINICAL ARTICLE; COMMON CAROTID ARTERY; CONTROLLED STUDY; DISEASE MARKER; ENDOTHELIAL DYSFUNCTION; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FIBRINOGEN BLOOD LEVEL; FIBRINOLYSIS; HEART INFARCTION; HUMAN; HUMAN CELL; INSULIN RESISTANCE; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; RISK FACTOR; WAIST HIP RATIO;

ADULT; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BODY MASS INDEX; BRACHIAL ARTERY; CAROTID ARTERY, COMMON; CAROTID INTIMA-MEDIA THICKNESS; CASE-CONTROL STUDIES; ENDOTHELIUM, VASCULAR; FIBRINOLYSIS; HUMANS; INFLAMMATION MEDIATORS; INSULIN; INSULIN RESISTANCE; LINEAR MODELS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; OBESITY, ABDOMINAL; PLASMINOGEN ACTIVATOR INHIBITOR 1; RISK FACTORS; UP-REGULATION; VASODILATION; WAIST-HIP RATIO;

EID: 84884675979     PISSN: 09108327     EISSN: 16152573     Source Type: Journal    
DOI: 10.1007/s00380-012-0287-9     Document Type: Article

References (37)

1. Stamler J, Stamler R, Neaton JD, Wentworth D, Daviglus ML, Garside D, Dyer AR, Liu K, Greenland P (1999) Low risk-factor profile and long-term cardiovascular and non-cardiovascular mortality and life expectancy: findings for 5 large cohorts of young adult and middle-aged men and women. JAMA 282:2012-2018
2. Kullo IJ, Gau GT, Tajik J (2000) Novel risk factors for atherosclerosis. Mayo Clin Proc 75:369-380
3. Ridker PM, Stampfer MJ, Rifai N (2001) Novel risk factors for systemic atherosclerosis. JAMA 285:2481-2485
4. Juhan-Vague I, Pyke S, Christine Alessi M, Jespersen J, Haverkate F (1996) Fibrinolytic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. Circulation 94:2057-2063
5. Mavri A, Alessi MC, Bastelica D, Geel-Georgelin O, Fina F, Šentočnik JT, Stegnar M, Juhan-Vague I (2001) Subcutaneous abdominal, but not femoral fat expression of plasminogen activator inhibitor-1 (PAI-1) is related to plasma PAI-1 levels and insulin resistance and decreases after weight loss. Diabetologia 44(11):2025-2031
6. Landin K, Stigendal L, Eriksson E, Krotkiewski M, Risberg B, Tengborn L, Smith U (1990) Abdominal obesity is associated with an impaired fibrinolytic activity and elevated plasminogen activator inhibitor-1. Metabolism 39:1044-1048
7. Vague P, Juhan-Vague I, Aillaud MF, Badier C, Viard R, Alessi MC, Collen D (1986) Correlation between blood fibrinolytic activity, plasminogen activator inhibitor level, plasma insulin level, and relative body weight in normal and obese subjects. Metabolism 35:250-253
8. Kohler HP (2002) Insulin resistance syndrome: interaction with coagulation and fibrinolysis. Swiss Med Wkly 132(19-20):241-252
9. Morricone L, Ferrari M, Enrini R, Inglese L, Giardini D, Garancini P, Caviezel F (1999) The role of central fat distribution in coronary artery disease in obesity: comparison of nondiabetic obese, diabetic obese, and normal weight subjects. Int J Obes Relat Metab Disord 23(11):1129-1135
10. Mavri A, Poredoš P, Suran D, Gaborit B, Juhan-Vague I, Poredoš P (2011) Effect of diet-induced weight loss on endothelial dysfunction: early improvement after the first week of dieting. Heart Vessels 26(1):31-38
11. Ikeda N, Nakajima R, Utsunomiya M, Hori M, Itaya H, Makino K, Ono T, Yamamoto M, Nemoto N, Iijima R, Hara H, Takagi T, Hara H, Nakamura M, Sugi K (2011) Higher body mass index at the time of acute myocardial infarction is associated with a favorable long-term prognosis (8-year follow-up). Heart Vessels 26(5):495-501
12. McGill JB, Schneider DJ, Arfken CL, Lucore CL, Sobel BE (1994) Factors responsible for impaired fibrinolysis in obese subjects and NIDDM patients. Diabetes 43:104-109
13. Vague P, Juhan-Vague I, Chabert V, Alessi MC, Atlan C (1989) Fat distribution and plasminogen activator inhibitor activity in nondiabetic obese women. Metabolism 38:913-915
14. Urano T, Kojima Y, Takahashi M, Serizawa K, Sakakibara K, Takada Y, Takada A (1993) Impaired fibrinolysis in hypertension and obesity due to high plasminogen activator inhibitor-1 level in plasma. Jpn J Physiol 43:221-228
15. De Pergola G, De Mitrio V, Perricci A, Cignarelli M, Garruti G, Lomuscio S, Ferri G, Schiraldi O, Giorgino R (1992) Influence of free testosterone on antigen levels of plasminogen activator inhibitor-1 in premenopausal women with central obesity. Metabolism 41:131-134
16. Juhan-Vague I, Vague P, Alessi MC, Badier C, Valadier J, Aillaud MF, Atlan C (1987) Relationships between plasma insulin, triglyceride, body mass index, and plasminogen activator inhibitor 1. Diabetes Metab 13:331-336
17. Juhan-Vague I, Thompson SG, Jespersen J (1993) Involvement of the hemostatic system in the insulin resistance syndrome. A study of 1500 patients with angina pectoris. The ECAT Angina Pectoris Study Group. Arterioscler Thromb 13:1865-1873
18. Hamsten A, Walldius G, Szamozi A, Blombäck M, de Faire U, Dahlen G, Landou C, Wiman B (1987) Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction. Lancet 2:3-9
19. Juhan-Vague I, Pyke SDM, Alessi MC, Jespersen J, Haverkate F, Thompson SG (1996) Fibrinolytic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. Circulation 96:2057-2063
20. Eržen B, Šabovič M, Šebeštjen M, Poredoš P (2007) Endothelial dysfunction, intima-media thickness, ankle-brachial pressure index, and pulse pressure in young post-myocardial infarction patients with various expressions of classical risk factors. Heart Vessels 22(4):215-222
21. Juhan-Vague I, Alessi MC, Joly P, Thirion X, Vague P, Declerck PJ, Serradimigni A, Collen D (1989) Plasma plasminogen activator inhibitor 1 in angina pectoris: influence of plasma insulin and acute-phase response. Arteriosclerosis 9:362-367
22. Haverkate F, Thompson SG, Duckert F (1995) Haemostasis factors in angina pectoris: relation to gender, age and acute-phase reaction. Thromb Haemost 73:561-567
23. Jansson JH, Olofsson BO, Nilsson TK (1993) Predictive value of tissue plasminogen activator mass concentration on long-term mortality in patients with coronary artery disease: a 7-year follow-up. Circulation 88:2030-2034
24. Celermajer DS, Sorensen KE, Spiegelhalter DJ, Georgakopoulos D, Robinson J, Deanfield JE (1994) Aging is associated with endothelial dysfunction in healthy men years before the age-related decline in women. J Am Coll Cardiol 24:471-476
25. Hashimoto M, Akishita M, Eto M, Ishikawa M, Kozaki K, Toba K, Sagara Y, Taketani Y, Orimo H, Ouchi Y (1995) Modulation of endothelium-dependent flow-mediated dilatation of the brachial artery by sex and menstrual cycle. Circulation 92:3431-3435
26. Scarpellini E, Tack J (2012) Obesity and metabolic syndrome: an inflammatory condition. Dig Des 30(2):148-153
27. Skalicky J, Muzakova V, Kandar R, Meloun M, Rousar T, Palicka V (2008) Evaluation of oxidative stress and inflammation in obese adults with metabolic syndrome. Clin Chem Lab Med 46(4):499-505
28. Fernández-Real JM, Ricart W (2003) Insulin resistance and chronic cardiovascular inflammatory syndrome. Endocr Rev 24(3):278-301
29. Reaven GM (2005) The insulin resistance syndrome: definition and dietary approaches to treatment. Annu Rev Nutr 25:391-406
30. Choi KM, Lee KW, Kim SG, Kim NH, Park CG, Seo HS, Oh DJ, Choi DS, Baik SH (2005) Inflammation, insulin resistance, and glucose intolerance in acute myocardial infarction patients without a previous diagnosis of diabetes mellitus. J Clin Endocrinol Metab 90(1):175-180
31. Ariza CR, Frati AC, Gómez G, Almazán A (1997) Hyperinsulinemia in patients with coronary heart disease in absence of overt risk factors. Arch Med Res 28(1):115-119
32. Ikeda N, Nakajima R, Tsunoda T, Nakamura M, Sugi K (2007) Insulin resistance and acute coronary syndrome in the young Japanese population have a strong association. Heart Vessels 22(3):165-169
33. DeFronzo RA, Tobin JD, Andres R (1979) Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237:E214-E223
34. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419
35. Ascaso JF, Romero P, Real JT, Priego A, Valdecabres C, Carmena R (2001) Insulin resistance quantification by fasting insulin plasma values and HOMA index in non-diabetic population. Med Clin (Barc) 117:530-533
36. Furumoto T, Fujii S, Saito N, Mikami T, Kitabatake A (2002) Relationships between brachial artery flow mediated dilation and carotid artery intima-media thickness in patients with suspected coronary artery disease. Jpn Heart J 43(2):117-125
37. Eržen B, Šabovič M, Šebeštjen M, Keber I, Poredoš P (2007) Interleukin-6 correlates with endothelial dysfunction in young post-myocardial infarction patients. Cardiology 107(2):111-116